Abstract
Mammary tumours were induced in 3 groups of male Long-Evans rats by a series of 6 fortnightly gastric intubations of 7,12-dimethylbenzanthracene. Two weeks before the initial carcinogen treatment one group of rats was grafted with 3 pituitary homografts underneath the kidney capsule of each recipient (hyperprolactinaemia). A second group, 2 weeks before the initial carcinogen treatment and for the duration of the study (35 weeks), were injected 4 X weekly with 2-Br-alpha-ergocryptine (CB-154) (hypoprolactinaemia). A third group of rats served as controls. A significant increase in the incidence of mammary tumours and a reduced latency period of tumour appearance in the hyperprolactinaemia group, when compared with the controls, were observed in this study. Mammary tumour incidence and latency period of tumour appearance in the hypoprolactinaemia group, however, did not differ significantly from controls. Thus, an increased secretion of pituitary prolactin in rats appears to be an important enhancing endocrinic condition in carcinogenesis of the male mammary gland.
Similar content being viewed by others
Rights and permissions
About this article
Cite this article
Welsch, C., Louks, G., Fox, D. et al. Enhancement by prolactin of carcinogen induced mammary cancerigenesis in the male rat. Br J Cancer 32, 427–431 (1975). https://doi.org/10.1038/bjc.1975.243
Issue Date:
DOI: https://doi.org/10.1038/bjc.1975.243
- Springer Nature Limited
This article is cited by
-
Prolactinoma through the female life cycle
Endocrine (2018)
-
Loss of mammary epithelial prolactin receptor delays tumor formation by reducing cell proliferation in low-grade preinvasive lesions
Oncogene (2007)
-
The prophylaxis of rat and mouse mammary gland tumorigenesis by suppression of prolactin secretion: A reappraisal
Breast Cancer Research and Treatment (1981)
-
The human pineal gland in malignancy
Journal of Neural Transmission (1980)